These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20631122)

  • 1. Annexin 2 is not required for human immunodeficiency virus type 1 particle production but plays a cell type-dependent role in regulating infectivity.
    Rai T; Mosoian A; Resh MD
    J Virol; 2010 Oct; 84(19):9783-92. PubMed ID: 20631122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anx2 interacts with HIV-1 Gag at phosphatidylinositol (4,5) bisphosphate-containing lipid rafts and increases viral production in 293T cells.
    Harrist AV; Ryzhova EV; Harvey T; González-Scarano F
    PLoS One; 2009; 4(3):e5020. PubMed ID: 19325895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Annexin 2: a novel human immunodeficiency virus type 1 Gag binding protein involved in replication in monocyte-derived macrophages.
    Ryzhova EV; Vos RM; Albright AV; Harrist AV; Harvey T; González-Scarano F
    J Virol; 2006 Mar; 80(6):2694-704. PubMed ID: 16501079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular Localization of HIV-1
    Becker JT; Sherer NM
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nucleocapsid domain of Gag is dispensable for actin incorporation into HIV-1 and for association of viral budding sites with cortical F-actin.
    Stauffer S; Rahman SA; de Marco A; Carlson LA; Glass B; Oberwinkler H; Herold N; Briggs JA; Müller B; Grünewald K; Kräusslich HG
    J Virol; 2014 Jul; 88(14):7893-903. PubMed ID: 24789788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body.
    Ono A; Freed EO
    J Virol; 2004 Feb; 78(3):1552-63. PubMed ID: 14722309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between HIV-1 Gag and Viral RNA Genome Enhance Virion Assembly.
    Dilley KA; Nikolaitchik OA; Galli A; Burdick RC; Levine L; Li K; Rein A; Pathak VK; Hu WS
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28539452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.
    Burdick R; Smith JL; Chaipan C; Friew Y; Chen J; Venkatachari NJ; Delviks-Frankenberry KA; Hu WS; Pathak VK
    J Virol; 2010 Oct; 84(19):10241-53. PubMed ID: 20668078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phosphorylation of HIV-1 Gag by atypical protein kinase C facilitates viral infectivity by promoting Vpr incorporation into virions.
    Kudoh A; Takahama S; Sawasaki T; Ode H; Yokoyama M; Okayama A; Ishikawa A; Miyakawa K; Matsunaga S; Kimura H; Sugiura W; Sato H; Hirano H; Ohno S; Yamamoto N; Ryo A
    Retrovirology; 2014 Jan; 11():9. PubMed ID: 24447338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in matrix and SP1 repair the packaging specificity of a Human Immunodeficiency Virus Type 1 mutant by reducing the association of Gag with spliced viral RNA.
    Ristic N; Chin MP
    Retrovirology; 2010 Sep; 7():73. PubMed ID: 20825656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.
    Jaber T; Bohl CR; Lewis GL; Wood C; West JT; Weldon RA
    J Virol; 2009 Oct; 83(20):10448-59. PubMed ID: 19640976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner.
    Demirov DG; Orenstein JM; Freed EO
    J Virol; 2002 Jan; 76(1):105-17. PubMed ID: 11739676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIP47 is required for the production of infectious HIV-1 particles from primary macrophages.
    Bauby H; Lopez-Vergès S; Hoeffel G; Delcroix-Genête D; Janvier K; Mammano F; Hosmalin A; Berlioz-Torrent C
    Traffic; 2010 Apr; 11(4):455-67. PubMed ID: 20070608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
    Freed EO; Englund G; Martin MA
    J Virol; 1995 Jun; 69(6):3949-54. PubMed ID: 7745752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nucleocapsid region of human immunodeficiency virus type 1 Gag assists in the coordination of assembly and Gag processing: role for RNA-Gag binding in the early stages of assembly.
    Ott DE; Coren LV; Shatzer T
    J Virol; 2009 Aug; 83(15):7718-27. PubMed ID: 19457986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins.
    Dettenhofer M; Yu XF
    J Virol; 1999 Jun; 73(6):4696-704. PubMed ID: 10233929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nef enhances HIV-1 infectivity via association with the virus assembly complex.
    Qi M; Aiken C
    Virology; 2008 Apr; 373(2):287-97. PubMed ID: 18191978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
    Sova P; Volsky DJ; Wang L; Chao W
    J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus particle release from glycosphingolipid-enriched microdomains is essential for dendritic cell-mediated capture and transfer of HIV-1 and henipavirus.
    Akiyama H; Miller C; Patel HV; Hatch SC; Archer J; Ramirez NG; Gummuluru S
    J Virol; 2014 Aug; 88(16):8813-25. PubMed ID: 24872578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.
    Trautz B; Pierini V; Wombacher R; Stolp B; Chase AJ; Pizzato M; Fackler OT
    J Virol; 2016 Dec; 90(23):10915-10927. PubMed ID: 27681140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.